Status: Not yet recruiting
Efficacy of Mavacamten Combined With Radiofrequency Ablation in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy
This study aims to evaluate the efficacy and safety of Mavacamten combined with radiofrequency ablation compared to Mavacamten alone in patients with symptomatic obstructive hypertrophic cardiomyopathy (HOCM). Participants were randomized into two groups:
Participants needed: 40
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Shanghai Chest HospitalUpdated: Mar 4, 2025
Eligibility criteria
At least 18 years old at screening. [+7]
1) Participated in a clinical trial in which the participant received any invest...